Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Quantitative methods for developing Fc mutants with extended half-lives.

Daniel T Kamei¹, Bert J Lao, Margaret Speed Ricci

¹Biotechnology Process Engineering Center, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA. kamei@seas.ucla.edu

Biotechnology and Bioengineering

|September 2, 2005

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

First implementation of a polymer-polymer aqueous two-phase system to improve lateral-flow immunoassay sensitivity via dextranase integration on paper.

Analytical sciences : the international journal of the Japan Society for Analytical Chemistry·2026

Same author

Development of an automated device and mobile application for digoxin detection and quantification from dried blood spots using gold-coated magnetic nanoprobes and the lateral-flow immunoassay.

Analytical and bioanalytical chemistry·2025

Same author

Development of a fully paper-based device for quantitative detection of digoxin at the point of care.

The Analyst·2025

Same author

Dual Chemotherapeutic Loading in Oxalate Transferrin-Conjugated Polymersomes Incorporated into Chitosan Hydrogels for Site-Specific Targeting of Melanoma Cells.

Pharmaceuticals (Basel, Switzerland)·2024

Same author

Investigating bottom phase extraction from aqueous two-phase systems for detecting bacteria using the lateral-flow immunoassay.

Analytical biochemistry·2024

Same author

Substrate Turnover Dynamics Guide Ketol-Acid Reductoisomerase Redesign for Increased Specific Activity.

ACS catalysis·2024

Same journal

Polycationic Peptide Engineering of Phage Endolysins Expands Host Range and Enhances Antibacterial and Antibiofilm Activities Against Bacillus Species.

Biotechnology and bioengineering·2026

Same journal

Artificial Intelligence-Powered Algal Biodiesel: The Future of Biofuel Production Through Data-Driven Biotechnology.

Biotechnology and bioengineering·2026

Same journal

Developing Anti-EGFR/Anti-HER2 Bifunctional Antibody for Solid Tumors by Protein Engineering.

Biotechnology and bioengineering·2026

Same journal

Bridging Organ-on-a-Chip and Omics: A Multi-Dimensional Frontier in Biomedical Research.

Biotechnology and bioengineering·2026

Same journal

Hemopexin Purification From Human Cohn Fraction IV Paste and Its Biophysical Characterization and Functional Evaluation in Sickle Cell Disease Mice.

Biotechnology and bioengineering·2026

Same journal

Characterization and Therapeutic Potential of a Novel Lytic Phage-Derived Endolysin PA16cLys Against Uropathogenic Pseudomonas aeruginosa Biofilms.

Biotechnology and bioengineering·2026

See all related articles

Engineered Fc fragments with higher binding affinity to the neonatal Fc receptor (FcRn) can extend therapeutic half-lives. New computational and cell-based methods help screen Fc mutants for improved binding and recycling, optimizing drug delivery.

Area of Science:

Biochemistry
Pharmacology
Molecular Biology

Background:

Engineering Fc fragments to bind the neonatal Fc receptor (FcRn) enhances therapeutic half-life.
Conjugating Fc fragments to other therapeutics can reduce injection frequency and toxicity.
Further optimization of Fc fragments is needed to maximize therapeutic benefits.

Purpose of the Study:

To develop quantitative methods for screening Fc mutants with enhanced FcRn binding affinity.
To investigate Fc fragment half-life extension strategies.
To complement existing in vivo testing and combinatorial screening approaches.

Main Methods:

Developed a molecular modeling procedure to predict binding free energies (DeltaDeltaGbind) between Fc and FcRn.
Formulated a mathematical model of Fc trafficking.

Related Experiment Videos

Combined modeling with cell-level pulse-chase assays to quantify Fc recycling in T84 cells.

Main Results:

The molecular modeling procedure reasonably reproduced experimental binding affinities.
The Fc recycling parameter correlated with binding affinity and captured pH-dependent interactions.
Both methods show potential for screening Fc sequence space and optimizing FcRn interactions.

Conclusions:

Computational and cell-based assays can effectively screen Fc mutants for improved FcRn binding and recycling.
These methods aid in developing Fc fragments with extended therapeutic half-lives.
Optimized Fc fragments can lead to improved drug delivery and reduced patient dosing frequency.